Search Results - "WEYER, Ute"
-
1
Bioreactor-Grown Bacillus of Calmette and Guérin (BCG) Vaccine Protects Badgers against Virulent Mycobacterium bovis When Administered Orally: Identifying Limitations in Baited Vaccine Delivery
Published in Pharmaceutics (18-08-2020)“…Bovine tuberculosis (TB) in Great Britain adversely affects animal health and welfare and is a cause of considerable economic loss. The situation is…”
Get full text
Journal Article -
2
Assessment of the safety of Bacillus Calmette-Guérin vaccine administered orally to badgers (Meles meles)
Published in Vaccine (05-04-2018)“…•Vaccinating badgers against TB is a tool under consideration to reduce the prevalence of bovine TB.•Showing an oral vaccine is safe for badgers and the…”
Get full text
Journal Article -
3
The Effect of Oral Vaccination with Mycobacterium bovis BCG on the Development of Tuberculosis in Captive European Badgers ( Meles meles )
Published in Frontiers in cellular and infection microbiology (24-01-2017)“…The European badger ( ) is a reservoir host of and responsible for a proportion of the tuberculosis (TB) cases seen in cattle in the United Kingdom and…”
Get full text
Journal Article -
4
Protection of Eurasian badgers ( Meles meles ) from tuberculosis after intra-muscular vaccination with different doses of BCG
Published in Vaccine (12-05-2011)“…Abstract Mycobacterium bovis infection is widespread in Eurasian badger ( Meles meles ) populations in Great Britain and the Republic of Ireland where they act…”
Get full text
Journal Article -
5
Purified galactooligosaccharide, derived from a mixture produced by the enzymic activity of Bifidobacterium bifidum, reduces Salmonella enterica serovar Typhimurium adhesion and invasion in vitro and in vivo
Published in Journal of medical microbiology (01-12-2010)“…The prebiotic Bimuno(®) is a mixture containing galactooligosaccharides (GOSs), produced by the galactosyltransferase activity of Bifidobacterium bifidum NCIMB…”
Get full text
Journal Article -
6
A mixture containing galactooligosaccharide, produced by the enzymic activity of Bifidobacterium bifidum, reduces Salmonella enterica serovar Typhimurium infection in mice
Published in Journal of medical microbiology (01-01-2009)“…1 Veterinary Laboratories Agency (VLA), Weybridge, Woodham Lane, New Haw, Addlestone, Surrey KT15 3NB, UK 2 Faculty of Veterinary Science, University of…”
Get full text
Journal Article -
7
Intermittent Escherichia coli O157:H7 colonisation at the terminal rectum mucosa of conventionally-reared lambs
Published in Veterinary research (Paris) (01-01-2009)“…In cattle, the lymphoid rich regions of the rectal-anal mucosa at the terminal rectum are the preferred site for Escherichia coli O157:H7 colonisation. All…”
Get full text
Journal Article -
8
Interaction of enterohemorrhagic Escherichia coli O157:H7 with mouse intestinal mucosa: EHEC O157:H7 in a mouse ileal loop model
Published in FEMS microbiology letters (01-06-2008)Get full text
Journal Article -
9
Interaction of enterohemorrhagic Escherichia coli O157:H7 with mouse intestinal mucosa
Published in FEMS microbiology letters (01-06-2008)“…In this study, we used mouse ileal loops to investigate the interaction of enterohemorrhagic Escherichia coli (EHEC) O157:H7 with the mouse intestinal mucosa…”
Get full text
Journal Article -
10
Intermittent Escherichia coli 0157:H7 colonisation at the terminal rectum mucosa of conventionally-reared lambs
Published in Veterinary research (Paris) (2009)Get full text
Journal Article